Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Current Assets: 2020-2025

Historic Current Assets for Molecular Partners Ag (MOLN) over the last 4 years, with Sep 2025 value amounting to $136,208.

  • Molecular Partners Ag's Current Assets fell 21.08% to $136,208 in Q3 2025 from the same period last year, while for Sep 2025 it was $136,208, marking a year-over-year decrease of 21.08%. This contributed to the annual value of $175.4 million for FY2024, which is 18.16% down from last year.
  • Molecular Partners Ag's Current Assets amounted to $136,208 in Q3 2025, which was down 6.47% from $145,632 recorded in Q2 2025.
  • Molecular Partners Ag's Current Assets' 5-year high stood at $264.4 million during Q4 2022, with a 5-year trough of $136,208 in Q3 2025.
  • In the last 3 years, Molecular Partners Ag's Current Assets had a median value of $206,436 in 2024 and averaged $35.9 million.
  • Its Current Assets has fluctuated over the past 5 years, first soared by 48.51% in 2022, then dropped by 28.07% in 2024.
  • Over the past 5 years, Molecular Partners Ag's Current Assets (Quarterly) stood at $178.1 million in 2021, then soared by 48.51% to $264.4 million in 2022, then decreased by 17.95% to $217.0 million in 2023, then dropped by 18.83% to $176.1 million in 2024, then dropped by 21.08% to $136,208 in 2025.
  • Its last three reported values are $136,208 in Q3 2025, $145,632 for Q2 2025, and $152,326 during Q1 2025.